Correlation Between Inozyme Pharma and Kamada
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Kamada at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Kamada into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Kamada, you can compare the effects of market volatilities on Inozyme Pharma and Kamada and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Kamada. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Kamada.
Diversification Opportunities for Inozyme Pharma and Kamada
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Inozyme and Kamada is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Kamada in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kamada and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Kamada. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kamada has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Kamada go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Kamada
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Kamada. In addition to that, Inozyme Pharma is 2.02 times more volatile than Kamada. It trades about -0.1 of its total potential returns per unit of risk. Kamada is currently generating about 0.04 per unit of volatility. If you would invest 601.00 in Kamada on November 8, 2024 and sell it today you would earn a total of 102.00 from holding Kamada or generate 16.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.6% |
| Values | Daily Returns |
Inozyme Pharma vs. Kamada
Performance |
| Timeline |
| Inozyme Pharma |
| Kamada |
Inozyme Pharma and Kamada Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Kamada
The main advantage of trading using opposite Inozyme Pharma and Kamada positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Kamada can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kamada will offset losses from the drop in Kamada's long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Kamada vs. Lifecore Biomedical | Kamada vs. Cumberland Pharmaceuticals | Kamada vs. Ironwood Pharmaceuticals | Kamada vs. Organogenesis Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |